VIPoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (20 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{VIPoma}} | {{VIPoma}} | ||
{{CMG}}{{AE}}{{MSI}}{{PSD}}{{Homa}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
[[Surgery]] is the [[mainstay]] of treatment for VIPoma. [[Surgery]] should be considered after initial [[symptomatic]] management of VIPoma [[inoperable]] cases. Complete [[surgical resection]] of the [[tumor]] is the only [[Cure|curative]] treatment for VIPoma. If the [[tumor]] cannot be removed completely, [[Surgery|surgical]] [[debulking]] may have [[Palliative therapy|palliative]] effect for [[control]] of [[hormonal]] [[symptoms]]. | |||
==Surgery== | ==Surgery== | ||
[[Surgery]] is the only curative | *[[Surgery]] is the mainstay of treatment for VIPoma.<ref name="sp">Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/</ref><ref name="pmid4981295">{{cite journal| author=Blaise A, Girardet JL| title=[Study of the magnetic properties of siderophilin]. | journal=C R Acad Sci Hebd Seances Acad Sci D | year= 1969 | volume= 269 | issue= 10 | pages= 966-8 | pmid=4981295 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4981295 }}</ref><ref name="DréanicLepère2016">{{cite journal|last1=Dréanic|first1=Johann|last2=Lepère|first2=Céline|last3=El Hajjam|first3=Mostafa|last4=Gouya|first4=Hervé|last5=Rougier|first5=Philippe|last6=Coriat|first6=Romain|title=Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?|journal=Therapeutic Advances in Medical Oncology|volume=8|issue=5|year=2016|pages=383–387|issn=1758-8340|doi=10.1177/1758834016656495}}</ref> | ||
*[[Surgery]] should be considered after initial [[symptomatic]] management of VIPoma [[inoperable]] cases. | |||
*Complete [[surgical resection]] of the [[tumor]] is the only [[Cure|curative]] treatment for VIPoma. | |||
*The feasibility of [[surgery]] depends on the stage of VIPoma at [[diagnosis]]. | |||
*If the [[tumor]] cannot be removed completely, [[Surgery|surgical]] [[debulking]] may have [[Palliative therapy|palliative]] effect for [[control]] of [[hormonal]] [[symptoms]]. | |||
*In nonresectable [[liver]] [[metastases]], [[hepatic]] [[Transcatheter arterial chemoembolization|TACE]] ([[Tace|transarterial chemoembolization]]) is emerging as a new non-emergency [[therapeutic]] [[modality]] highly successful for [[control]] of VIP-related [[symptoms]]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Endocrinology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 00:40, 30 July 2020
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma surgery On the Web |
|
American Roentgen Ray Society Images of VIPoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3] Homa Najafi, M.D.[4]
Overview
Surgery is the mainstay of treatment for VIPoma. Surgery should be considered after initial symptomatic management of VIPoma inoperable cases. Complete surgical resection of the tumor is the only curative treatment for VIPoma. If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.
Surgery
- Surgery should be considered after initial symptomatic management of VIPoma inoperable cases.
- Complete surgical resection of the tumor is the only curative treatment for VIPoma.
- The feasibility of surgery depends on the stage of VIPoma at diagnosis.
- If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.
- In nonresectable liver metastases, hepatic TACE (transarterial chemoembolization) is emerging as a new non-emergency therapeutic modality highly successful for control of VIP-related symptoms.
References
- ↑ Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/
- ↑ Blaise A, Girardet JL (1969). "[Study of the magnetic properties of siderophilin]". C R Acad Sci Hebd Seances Acad Sci D. 269 (10): 966–8. PMID 4981295.
- ↑ Dréanic, Johann; Lepère, Céline; El Hajjam, Mostafa; Gouya, Hervé; Rougier, Philippe; Coriat, Romain (2016). "Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?". Therapeutic Advances in Medical Oncology. 8 (5): 383–387. doi:10.1177/1758834016656495. ISSN 1758-8340.